---
title: 'Associate Director, Supply Chain Product Planning at IMVT Corporation'
canonical: 'https://feeny.ai/job/associate-director-supply-chain-product-planning-imvt-corporation-remote-xhnnchmc99f3'
type: 'job'
last_seen: '2026-09-11'
---

# Associate Director, Supply Chain Product Planning at IMVT Corporation

- **Company:** IMVT Corporation
- **Location:** Remote
- **Compensation:** $170k–$190k
- **Work type:** remote
- **Posted:** 2026-08-14
- **Last confirmed live:** 2026-09-11
- **Apply:** https://job-boards.greenhouse.io/imvtcorporation/jobs/6144649004

## Job description

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.

The Role:

Reporting to the Senior Director, Global Supply Chain and Logistics, this position is responsible for integrated clinical and commercial product planning. The Associate Director, Supply Chain Product Planning, partners with the clinical supply chain, commercial supply chain, CMC-project management, CMC-QA, and CMO project core teams to obtain forecasts, which the Associate Director will then use to generate/update the master production schedule across multiple, global, external CMOs. This role also monitors global stock levels, sets safety stock guidelines, tracks expirations, and allocates bulk materials.

Key Responsibilities:

- Develop and maintain the combined clinical and commercial forecasts within the supply chain management system (SCMS) planning and inventory management tool based on actual demands and future projection inputs from clinical and commercial teams.
- Translate clinical trial enrollment schedules and commercial sales forecasts into the master production plan for drug substance, drug product, drug/device combination products, clinical finished goods, and commercial finished goods.
- Allocate drug substance batches to clinical versus commercial end use, considering Regulatory-driven material requirements.
- Build and maintain item/material masters within SCMS tool.
- Contribute supply chain input into cross-functional CD&OP/S&OP processes.
- Provide supply plan requests to CMO core teams at vendor-specific frequency and integrate endorsed manufacturing schedules into master production plan within the SCMS.
- Generate and communicate bulk material allocations and associated finished goods production plans to clinical and commercial supply colleagues to support operational execution of finished good batch production at packaging and labeling vendors.
- Establish safety stock guidelines for materials across the global supply chain, project future inventory positions, and prevent overstocking or stockouts for clinical and commercial materials.
- Monitor global stock levels, safety stock, and expiration dates.
- Respond to dynamic clinical and commercial projections by developing/comparing various scenarios and determine/communicate the associated impact across end-to-end materials.
- Partner with finance to determine the budget impact of various planning scenarios.
- Identify supply bottlenecks, manage lead times, and maintain operational continuity under strict GxP rules.
- Support commercial launch readiness activities.

Requirements:

- Bachelor's degree in biotechnology, life sciences, supply chain, business, engineering or another relevant field.
- 7+ years of relevant biopharmaceutical industry experience.
- 3+ years in production planning, inventory control, or demand forecasting for both clinical and commercial materials within the biotech, pharmaceutical, or regulated life sciences sectors.
- Experience using multiple systems for planning, forecasting, inventory management and ERP processes.
- Excellent understanding of manufacturing processes for drug substance, drug product, drug/device combination products, clinical finished goods, and commercial finished goods.
- Very good understanding of cGMP and Regulatory requirements as it pertains to material releases, country requirements, etc.
- Strong computer skills including MS Office, Excel, SharePoint, etc.
- Hands-on, roll-up-your-sleeves approach with high sense of urgency and drive for results.
- Demonstrate strong communication & problem-solving, excellent organization skills.
- Strong capability to build relationships across the organization and externally.
- Technical, operational, and business-oriented mindset capable of analyzing and resolving complex, multifaceted issues through solid problem-solving skills.
- Ability to think outside of the box and challenge the status quo.
- Natural entrepreneurial spirit with unrelenting dedication to delivering results.
- Desire to work in a fast-paced, dynamic, and innovative environment.
- Natural collaborator who enjoys working on a cross-functional team.
- Strong working knowledge of cGMP and GDP requirements.

- Work Environment:

- Remote-based
- Dynamic, interactive, fast-paced, and entrepreneurial environment
- Domestic or international travel is required (10-20%)

Salary range for posting $170,000—$190,000 USD

Compensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.

## About IMVT Corporation

## Company Overview
- **One-liner**: A clinical-stage immunology company developing innovative anti-FcRn therapies to enable normal lives for people with autoimmune diseases.
- **Entity Type**: Public (Nasdaq: IMVT)
- **Headquarters**: Durham, North Carolina, United States
- **Founded**: Not publicly available
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology / Autoimmune disease therapeutics
- **Target customers**: Patients with IgG-mediated autoimmune diseases; healthcare providers; payers (B2B/B2C mix via prescription drugs)
- **Mission or purpose statement**: “Dedicated to enabling normal lives for people with autoimmune diseases” [immunovant.com](https://www.immunovant.com/)

## Products & Services
- **[IMVT-1402 (imeroprubart)]**: A novel, fully human monoclonal antibody that targets FcRn to reduce pathogenic IgG autoantibodies. Designed as a subcutaneous injection with a simple autoinjector (YpsoMate®). In clinical development for six indications: Graves’ disease (GD), difficult-to-treat rheumatoid arthritis (D2T RA), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), Sjögren’s disease (SjD), and cutaneous lupus erythematosus (CLE). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **[Batoclimab (first-generation anti-FcRn)]**: Development discontinued across all indications after Phase 3 TED trials did not meet primary endpoints; learnings inform IMVT-1402 program. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Market Standing
- **Valuation/Market Cap**: Not disclosed in available sources (publicly traded on Nasdaq; refer to real-time market data).
- **Key Metric**: Clinical-stage company with no approved products or revenue; total funding and operating expenses are detailed in SEC filings but not summarized here.
- **Notable Investors/Partners**: HanAll Biopharma (collaboration on anti-FcRn antibodies); Ypsomed AG (auto-injector YpsoMate®). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **Growth Signals**: Six ongoing clinical programs (including potentially registrational trials); deep IgG reductions (~80% with weekly 600 mg IMVT-1402) suggesting best-in-class potential; Phase 1 safety data showing no/minimal albumin reduction or LDL cholesterol increases. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Competitive Advantages
- **Potential best-in-class efficacy**: IMVT-1402 achieves deeper IgG reductions than competitor anti-FcRn antibodies, correlating with improved clinical outcomes.
- **Favorable safety profile**: No or minimal off-target effects on albumin and LDL cholesterol, unlike some FcRn inhibitors.
- **Convenient administration**: Self-administered subcutaneous autoinjector (YpsoMate®) expected at launch, improving patient adherence.
- **Broad pipeline**: Six indications in development across endocrinology, rheumatology, neurology, and dermatology, with potential for more.

## Strategic Focus
- Execute pivotal trials for IMVT-1402 in GD, D2T RA, MG, CIDP, SjD, and CLE.
- Leverage learnings from batoclimab program to accelerate IMVT-1402 development.
- Plan to assess new indications for IMVT-1402 beyond the initial six.
- Continue to build commercial capabilities for eventual launch. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Why Work Here
- **Culture**: Emphasizes “Hire and Retain Only the Very Best,” “One Team, Shared Success,” “Ownership Mentality,” and “Patients Are Waiting” – a mission-driven, high-performance environment. [About Us](https://www.immunovant.com/about-us)
- **Remote/Hybrid Policy**: Job listings show a mix of remote and hybrid roles (e.g., “Remote” for many positions, “Hybrid - NYC” for commercial roles). [Careers](https://www.immunovant.com/join-us/explore-careers)
- **Notable Perks**: Merit-based recognition, focus on impact and results, creative problem-solving encouraged. [About Us](https://www.immunovant.com/about-us)
- **Engineering/Science Culture**: Clinical-stage biotech with cutting-edge FcRn technology; opportunities in clinical development, biometrics, quality assurance, and commercial roles. [Careers](https://www.immunovant.com/join-us/explore-careers)

## Sources
1. [Immunovant Corporate Website](https://www.immunovant.com/)
2. [About Us – Values and Culture](https://www.immunovant.com/about-us)
3. [Company Information – Investor Relations](https://www.immunovant.com/investors/company-information)
4. [Explore Careers – Job Listings](https://www.immunovant.com/join-us/explore-careers)
5. [10-K SEC Filing (May 20, 2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Other roles at IMVT Corporation

- [Senior Director, Data Management Systems](https://feeny.ai/job/senior-director-data-management-systems-imvt-corporation-remote-bw7zc2r5bz1x)
- [Executive Assistant](https://feeny.ai/job/executive-assistant-imvt-corporation-new-york-m7dv0wr8rkjs) — New York, NY
- [Senior Manager, QC](https://feeny.ai/job/senior-manager-qc-imvt-corporation-remote-a2g9683h4zsg)
- [Senior Director, Biostatistics](https://feeny.ai/job/senior-director-biostatistics-imvt-corporation-remote-swdw529e6zxr)
- [Director, Medical Science Liaison (MSL)](https://feeny.ai/job/director-medical-science-liaison-msl-imvt-corporation-southeast-cnykwbftkpjw) — Southeast
- [Director, Marketing](https://feeny.ai/job/director-marketing-imvt-corporation-remote-4t6kt28mgdh0)